Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Are smart watches and other wearable tech about to take over primary healthcare? Writing in the news and perspectives section of the Journal of Medical Internet Research (JMIR) med tech expert Blythe Karow last week made the case that we are in danger of ceding control of health care to big tech. Karow, a correspondent […]

The post Bulletin: Expert warns big tech could become ‘Health care gatekeepers’ appeared first on Medical News Bulletin.

DENVER — SightGlass Diffusion Optics Technology spectacle lenses led to 67% slower myopia progression over 2 years in a study of Chinese children.
The 2-year findings from SightGlass Vision’s CATHAY study were recently presented at the Association for Research in Vision and Ophthalmology meeting in Denver. The Diffusion Optics Technology (DOT) lens previously showed efficacy in a 4-year North American study, but it is not yet FDA approved.
The CATHAY study included data on 172 children aged 6 to 13 years enrolled at five sites in China, according to a press release.
The results

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, shares highlights from his discussion with a patient about their experiences living with IgA nephropathy.
“Both for her experience and for my experience, there wasn’t much that they could offer us when we got our diagnosis, and as our kidney function continued to decline, leading toward dialysis,” said Hassler, associate professor of pathology and laboratory medicine at the Lewiz Katz School of Medicine at Temple University.
They discussed the new treatment options becoming available

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, discusses how the pathology and symptoms of IgA nephropathy are used to recognize and diagnose the disease.
“[I explained] the clinical signs and symptoms of IgA nephropathy, as well as what we see under the microscope, and how that important information is used by the clinicians, my nephrology colleagues, the nurse practitioners ... to help improve outcomes for these patients,” said Hassler, associate professor of pathology and laboratory medicine at the Lewiz Katz

When diagnosing periprosthetic joint infection, a machine learning-driven probability score had high diagnostic accuracy and lower uncertainty vs. physicians, as well as significant clinical and economic advantages, according to results.
“For surgeons, this means greater confidence at the point where the decision matters the most,” Krista O’Shaughnessey Toler, MS, MBA, PMP, director of research and development for infection solutions at Zimmer Biomet, told Healio. “Instead of getting an inconclusive result that still forces a treatment decision, a probability-based

CHICAGO — Adding an immunotherapy-based regimen to standard treatment may improve outcomes for some patients with liver cancer who are not candidates for surgery, according to results of the randomized phase 3 EMERALD-3 study.
Using STRIDE — single-agent tremelimumab (Imjudo, AstraZeneca) and regular-interval durvalumab (Imfinzi, AstraZeneca) — with transarterial chemoembolization (TACE) significantly improved PFS among patients with embolization-eligible hepatocellular carcinoma.
The benefit appeared consistent regardless of whether the targeted therapy lenvatinib (Lenvima, Eisai) had been

Click here to read the Healio Exclusive, “EyeSustain, industry collaborate to reduce waste.”
Right now, a significant amount of waste in ophthalmology comes from mandated chemical high-level disinfection.
Multiple exposures to high-level disinfection (HLD) can damage delicate ophthalmic equipment and often lead to single-use policies, like disposable tonometer tips and single-use goniotomy or laser lenses. Studies show that single-use tonometry prisms and gonioscopy lenses produce more than 100 kg of plastic waste in a large ophthalmology outpatient department and cost close to $1 million over

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to someone with the disease, according to the drug’s manufacturer, Shionogi.
Xocova (ensitrelvir) was approved as COVID-19 post-exposure prophylaxis for patients aged 12 years or older, the drug maker announced.
The oral antiviral is taken over 5 days, beginning with three tablets on the first day and followed by a single tablet on each of the next 4 days.
The approval, which came more than 2 weeks earlier than the June 16 deadline set by the FDA last year, arrives

Metabolic health is a central concept in obesity medicine, yet it is often misunderstood or reduced to weight alone.
For individuals living with obesity, metabolic health is about far more than the number on the scale. It reflects how the body processes energy, regulates blood sugar, manages lipids and supports long-term health.
Nutrition plays a major role in this process. Food choices influence insulin resistance, inflammation and overall metabolic function, all of which are closely tied to obesity and cardiometabolic disease. In clinical practice, helping patients understand metabolic health

ORLANDO — Patients in the ICU with more inflammation and more severe illness demonstrated less cognitive resilience, according to an abstract presented at the American Thoracic Society International Conference.
However, patients who received care in a Veterans Administration hospital demonstrated more cognitive resilience, Matthew Franklin Mart, MD, assistant professor, Vanderbilt University School of Medicine, said during his presentation.
“Cognitive impairment is extremely common in our ICU survivors, and it’s oftentimes on par with that of mild cognitive impairment or traumatic brain injury